Anzeige
Mehr »
Login
Montag, 29.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Basin Uranium: Es geht los! Der Uran-Superzyklus ist gestartet!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
151 Leser
Artikel bewerten:
(0)

Optel Vision EMEA Office officially opened by the Minister of Finance, Mr. Michael Noonan TD

LIMERICK, Ireland, Nov. 27, 2014 /PRNewswire/ -- The Minister of Finance, Mr. Michael Noonan TD, officially opened the Optel Vision EMEA Office in the presence of dignitaires from Ireland along with customers and partners from all Europe and the Americas. It is with great pleasure that, Optel Vision, the leading Canadian company specializing in Track & Trace and vision inspection solutions for the manufacturing industries has now opened a new state-of-the-art facility in Ireland to serve its customers across Europe.

Photo - http://photos.prnewswire.com/prnh/20141127/161326

"Optel Vision is a technology leader in the fast growing pharmaceutical Track & Trace market and an excellent fit for the automation and life sciences sector in Ireland. I am delighted to mark the official opening of Optel Vision's EMEA Office in Limerick. I look forward to working with Optel Vision as they grow this operation in Ireland". says Mr. Noonan.

This new site will be the turning point for our European operation. The facility will be executing the engineering and final stage testing of our solutions. Customers will be able to visit the Limerick plant for their equipment FATs. The facility will also serve as a training and demo center.

At this new location, Optel Vision will create 140 new jobs in Limerick as part of a new European expansion. The roles will be created over the next five years in engineering, design, assembly, testing, customer support, sales, H.R., finance and administration activities.

This important international development has been a dream come true for Louis Roy who founded Optel Vision in 1989. Through his perseverance and dedication and the passion of the Optel Vision team, the company has been able to position itself as a leader in its field.

Along with celebrating the grand opening and its 25th Anniversary, Optel Vision has also organized a Technical Symposium on Track & Trace to discuss the various challenges involved within the serialisation Industry. Customers and partners attending this event will engage in various conferences and discussions in order to help pharmaceutical companies with their Track & Trace implementation challenges across Europe.

"With the mission of protecting the public through cutting edge technologies, Optel Vision is preparing itself to support the pharmaceutical industry across the globe in its fight against counterfeit medicines that represent a threat to the populations globally. It is with this maturity and its firm ground that the company faces the next 25 years. With infinite innovation opportunities to realize its mission, Optel Vision will be able to deploy its solutions with a team of experts all around the world" says Mr. Louis Roy, President of Optel Vision.

About Optel Vision

Optel Vision specializes in the development and manufacture of innovative vision inspection and Track & Trace solution for the pharmaceutical industry. Every day, the company ensures the quality of billions of products in over twenty countries, including Canada, the United States, Europe, China and India. The technology developed by Optel Vision allows the detection of errors in manufacturing and packaging on production lines of major pharmaceutical manufacturers, dramatically reducing the risks to public health.

Media Contact
Ken Fallu, Marketing & Product Management Director
+1-418-955-7052
ken.fallu@optelvision.com

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2014 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.